EUVIMEDEUVIMED entdecken
Crossref

L26/P-663 Clinical and ongoing pregnancy outcomes after single euploid and mosaic blastocyst transfer according to mosaic type and level

E.A. Park, S.N. Hwang, M. Kang, Y.R. Park, H.S. Kim, S. Sung, J.Y. Park, Y.R. Choi, K.A. Lee, J.Y. Choi, S.J. Han, M.J. Kim und 3 weitere

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.993 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von E.A. Park und 14 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Do mosaic type and level independently influence clinical and ongoing pregnancy outcomes after single frozen-thawed blastocyst transfer? Summary answer Whole-chromosome high-level mosaic embryos showed markedly reduced rates of clinical and ongoing pregnancy, whereas other mosaic subtypes showed pregnancy outcomes comparable to euploid embryos. What is known already An increasing number of reports suggest that mosaic embryos can result in healthy live births, and their transfer is increasingly considered when euploid embryos are unavailable. Existing evidence indicates that pregnancy outcomes vary according to mosaic characteristics, with segmental mosaicism generally associated with higher pregnancy rates than whole-chromosome mosaicism, and low-level mosaicism associated with better outcomes than high-level mosaicism. However, few studies have simultaneously evaluated the independent effects of mosaic type and level on both clinical and ongoing pregnancy after single embryo transfer while accounting for relevant parental and endometrial covariates. Study design, size, duration This retrospective cohort study included 2,898 single frozen–thawed blastocyst transfer cycles performed between August 2020 and June 2025. Euploid and mosaic embryos identified by preimplantation genetic testing for aneuploidy (PGT-A) were analyzed. Participants/materials, setting, methods Infertile women undergoing single blastocyst transfer after PGT-A were included. Mosaic embryos were classified by type (segmental or whole-chromosome) and level (low or high). Pregnancy outcomes were compared using multivariable logistic regression adjusted for maternal age, paternal age, body mass index, anti-Müllerian hormone level, and endometrial thickness. Main results and the role of chance Among 2,898 single frozen embryo transfer cycles, 2,569 involved euploid embryos and 329 involved mosaic embryos, subdivided into segmental low-level (n = 154), segmental high-level (n = 30), whole-chromosome low-level (n = 118), and whole-chromosome high-level (n = 27). Patients receiving whole-chromosome high-level mosaic embryos were older and had thinner endometrium than those receiving euploid embryos. Clinical pregnancy rates were lowest in the whole-chromosome high-level mosaic group (29.6%), compared with euploid embryos (59.6%). Ongoing pregnancy rates were markedly reduced in this group (11.1% vs. 51.0%), accompanied by a higher miscarriage rate (62.5% vs. 14.4%). In multivariable analyses, whole-chromosome high-level mosaic embryos were associated with significantly lower odds of clinical pregnancy (adjusted odds ratio [aOR] 0.35, 95% confidence interval [CI] 0.15–0.82; p = 0.015) and ongoing pregnancy (aOR 0.14, 95% CI 0.04–0.48; p = 0.002) compared with euploid embryos. No significant differences were observed for segmental low-level, segmental high-level, or whole-chromosome low-level mosaic embryos. Greater endometrial thickness was independently associated with higher odds of both outcomes (p < 0.001). Limitations, reasons for caution The retrospective design and clinician-driven embryo selection may introduce residual confounding. Nevertheless, consistent findings across clinical and ongoing pregnancy outcomes support the robustness of the observed association. Wider implications of the findings These findings suggest that not all mosaic embryos carry equivalent reproductive risk and support cautious consideration of mosaic subtype and level when prioritizing embryos for transfer. Trial registration number No

Zitieren

APA

Park, E., Hwang, S., Kang, M., Park, Y., Kim, H., Sung, S., Park, J., Choi, Y., Lee, K., Choi, J., Han, S., Kim, M., Kim, H., Kim, Y., & Yu, E. (2026). L26/P-663 Clinical and ongoing pregnancy outcomes after single euploid and mosaic blastocyst transfer according to mosaic type and level. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.993

Vancouver

Park E, Hwang S, Kang M, Park Y, Kim H, Sung S, et al. L26/P-663 Clinical and ongoing pregnancy outcomes after single euploid and mosaic blastocyst transfer according to mosaic type and level. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.993

BibTeX
@article{Park2026,
  author = {Park, E.A. and Hwang, S.N. and Kang, M. and Park, Y.R. and Kim, H.S. and Sung, S. and Park, J.Y. and Choi, Y.R. and Lee, K.A. and Choi, J.Y. and Han, S.J. and Kim, M.J. and Kim, H.O. and Kim, Y.S. and Yu, E.J.},
  title = {L26/P-663 Clinical and ongoing pregnancy outcomes after single euploid and mosaic blastocyst transfer according to mosaic type and level},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.993}
}
Kostenlos starten →